Diligence memo · auto-generated · as of July 2, 2026

ClearDynamic Inc.

ClearDynamic Inc. looks fair against its niche peers and is active on financing cadence.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

ClearDynamic Inc. operates in Biotechnology, based in HALIFAX.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

ClearDynamic Inc. has raised $2.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.0M on 2025-11-05.

Most recent recorded round closed around 2025-11-05.

Valuation (modeled)modeled

Provath models ClearDynamic Inc. at approximately $4.6M (range $1.4M–$8.5M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.01× the median modeled value of Seed Biotechnology companies in 2025–2027 (99 peers) — value vs value, same stage and era. Within the normal band (101% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 8 mo ago; this sector typically re-raises about every 14 months.

Raising on or ahead of the sector's normal rhythm.

Comparablesmixed

Capital scale ranks ahead of 27% of Biotechnology peers (4293 compared).

Modeled value ranks above 10% of those peers.

Closest niche peers: Carna Inc., NRX Pharmaceuticals, Inc., Vicora, Inc., MH3D, Inc., Oral Genome Corp..

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.